Sabinsa Receives European Patent for ForsLean®

Sabinsa Receives European Patent for ForsLean®

PISCATAWAY, N.J.Sabinsa Corp. received a European patent (#98 907 537 9) for the use offorskolin, the active compound in Sabinsas ForsLean® Coleusforskohlii extract, for promoting lean body mass,reducing fat tissue and encouraging weight loss. The patent encompasses allEuropean countries, and Sabinsa plans to make the claims and patent numberavailable to dietary supplement manufacturers and marketers in Europe through anon-exclusive licensing agreement.

We have spent tremendous time and resources confirming thesafety and efficacy of our ForsLean ingredient, and we are pleased that this usepatent was granted, said Todd Norton, Sabinsas president. This patentensures that customers in Europe are receiving our quality Coleus forskohliiextract and it offers them legal protection and rights for our intellectualproperty in Europe.

ForsLean is supplied in Europe by several companies, includingSochim International (www.sochim.com) in Milan, Italy; Gee Lawson Nutritional(www.geelawson.co.uk) in London; Mivalied in Germany; Silvaco in Hillerod,Denmark; and Brenntag-Nordic (www.brenntag-nordic.com) with offices throughoutScandinavia.

For more information, visitwww.forslean.com or Booth #1603-1605 at SupplySide East.